Article Details

Ex-Pfizer CEO's startup Centrexion gets $67M for PhIII painkiller

Retrieved on: 2018-01-01 21:07:30

Tags for this article:

Click the tags to see associated articles and topics

Ex-Pfizer CEO's startup Centrexion gets $67M for PhIII painkiller. View article details on hiswai:

Excerpt

<div>For the new round, <b>New Enterprise Associates</b> led the financing with participation from new and existing investors, including Quan Capital and ArrowMark Partners, among others. As part of the financing, Centrexion named NEA partner Sara Nayeem and Quan's managing director Stella Xu to its board ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up